Integrated Medical Professionals, PLLC

New York, New York 10016

3 studies enrolling now · 5 studies all time

What they study most

Bladder Cancer, Intermediate Risk Non-Muscle Invasive Bladder Cancer, Localized Prostate Cancer, Non Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Urologic Cancer, Urothelial Carcinoma

Studies at this site

• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• WATER IV PCa (AS Sub-study) — Starting soon
• A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT — Running, not enrolling
• WATER IV Prostate Cancer — Running, not enrolling
• An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG — Available (expanded access)